Metabolic SyndromeNCT07766928
Lipid and Glucose Response to Plant-based and Regular Burgers
A study testing Acute consumption of different burger types in people with Metabolic Syndrome, run by University of Saskatchewan at 1 site in Canada.
Trial summary
This study evaluates the blood lipid and glucose response to two burgers: 1) A plant-based meat alternative burger and 2) a regular beef burger in a cross-over trial. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Metabolic Syndrome
- What is being tested?
- Acute consumption of different burger types
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteCanada
- Study dates
- 17 Aug 2026to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Body mass index 25 or higher
Who cannot join
- Not diagnosed with diabetes
- Not on any medications for glucose or lipids
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site
College of Kinesiology, University of Saskatchewan
Saskatoon, Saskatchewan, S7N 5B2
PHILIP Chilibeck, PhD, 3062303849, phil.chilibeck@usask.ca
About this study
Official title: Assessment of Postprandial Response After Consumption of Plant-based Burgers
This study evaluates the blood lipid and glucose response to two burgers: 1) A plant-based meat alternative burger and 2) a regular beef burger in a cross-over trial.
Read the detailed description
Postprandial blood lipids and glucose are risk factors for cardiovascular disease. This study evaluates the postprandial response to consuming a plant-based meat-alternative burger and a regular beef burger. Ten participants will consume each burger on separate days. Blood lipids, glucose, and blood pressure will be assessed for six hours after each condition.
- Conditions
- Metabolic Syndrome
- Being tested
- Acute consumption of different burger types
- Medical subject headings
- Metabolic Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Acute consumption of different burger typesDietary supplement
Consumption of beef (animal-based) vs pea (plant-based) burgers
| Study group | Role | What they receive |
|---|---|---|
| Plant-based burger | Experimental | Plant-based meat alternative burger Receives: Dietary Supplement: Acute consumption of different burger types |
| Beef burger | Experimental | Regular beef burger Receives: Dietary Supplement: Acute consumption of different burger types |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in triglycerides (mmol/L)
Blood measure of triglycerides
Measured: 6 hours
Secondary outcomes (6)
Change in glucose (mmol/L)
Blood measure of glucose
Measured: 6 hours
Change in cholesterol (mmol/L)
blood measure of cholesterol
Measured: 6 hours
Change in high density lipoprotein (mmol/L)
blood measure of high density lipoprotein
Measured: 6 hours
Change in low density lipoprotein (mmol/L)
blood measure of low density lipoprotein
Measured: 6 hours
Change in systolic blood pressure (mmHg)
systolic blood pressure measured with a sphygmomanometer
Measured: 6 hours
Change in diastolic blood pressure (mmHg)
diastolic blood pressure measured with a sphygmomanometer
Measured: 6 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Aug 2026
- Study start17 Aug 2026 (estimated)
- Primary completion30 Sep 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Metabolic SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Saskatchewan
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Phil Chilibeck, University of Saskatchewan
- Investigators
- PHILIP Chilibeck, PhD, Principal investigator, University of Saskatchewan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07766928
- Sponsor's protocol ID
- 5272
- Status last verified
- Aug 2026
- First submitted
- 10 Aug 2026
- Last updated
- 17 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Postprandial Response After Consumption of Plant-based Burgers
- ClinicalTrials.gov ID
- NCT07766928
- Acronym / sponsor ID
- 5272
- Conditions
- Metabolic Syndrome
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- University of SaskatchewanUniversity, hospital or other
- Study start
- 17 Aug 2026 (estimated)
- Primary completion
- 30 Sep 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 17 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the blood lipid and glucose response to two burgers: 1) A plant-based meat alternative burger and 2) a regular beef burger in a cross-over trial.
Detailed description
Postprandial blood lipids and glucose are risk factors for cardiovascular disease. This study evaluates the postprandial response to consuming a plant-based meat-alternative burger and a regular beef burger. Ten participants will consume each burger on separate days. Blood lipids, glucose, and blood pressure will be assessed for six hours after each condition.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Plant-based burger | Experimental | Dietary Supplement: Acute consumption of different burger typesPlant-based meat alternative burger |
| Beef burger | Experimental | Dietary Supplement: Acute consumption of different burger typesRegular beef burger |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Body mass index 25 or higher
Key exclusion criteria (2 listed)
- Not diagnosed with diabetes
- Not on any medications for glucose or lipids
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Acute consumption of different burger typesConsumption of beef (animal-based) vs pea (plant-based) burgers | Dietary supplement | Beef burger, Plant-based burger |
Primary outcome
Change in triglycerides (mmol/L)
Time frame: 6 hours
Blood measure of triglycerides
6 secondary outcomes
Change in glucose (mmol/L)
Time frame: 6 hours
Change in cholesterol (mmol/L)
Time frame: 6 hours
Change in high density lipoprotein (mmol/L)
Time frame: 6 hours
Change in low density lipoprotein (mmol/L)
Time frame: 6 hours
Change in systolic blood pressure (mmHg)
Time frame: 6 hours
Change in diastolic blood pressure (mmHg)
Time frame: 6 hours
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Aug 2026.
Related trials for Metabolic Syndrome
RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Not yet recruitingPhase 2
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
PHILIP Chilibeck, PhD principal investigator
University of Saskatchewan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Acute consumption of different burger types in people with Metabolic Syndrome, run by University of Saskatchewan at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact PHILIP Chilibeck, PhD (3062303849, phil.chilibeck@usask.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in triglycerides (mmol/L) (time frame: 6 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.